Fulltext

Perceptions and behaviours of infectious diseases physicians when managing urinary tract infections due to MDR organisms

Trevino, Sergio E. ; Babcock, Hilary M. ; Henderson, Jeffrey P. ; Lane, Michael A. ; Beekmann, Susan E. ; Polgreen, Philip M. ; Marschall, Jonas

In: Journal of Antimicrobial Chemotherapy, 2015, vol. 70, no. 12, p. 3397-3400

Zum persönliche Liste hinzufügen
    Titel
    • Perceptions and behaviours of infectious diseases physicians when managing urinary tract infections due to MDR organisms
    Autor
    • Trevino, Sergio E.. Division of Infectious Diseases, Washington University School of Medicine, 660 S. Euclid, St Louis, MO 63110, USA
    • Babcock, Hilary M.. Division of Infectious Diseases, Washington University School of Medicine, 660 S. Euclid, St Louis, MO 63110, USA
    • Henderson, Jeffrey P.. Division of Infectious Diseases, Washington University School of Medicine, 660 S. Euclid, St Louis, MO 63110, USA
    • Lane, Michael A.. Division of Infectious Diseases, Washington University School of Medicine, 660 S. Euclid, St Louis, MO 63110, USA
    • Beekmann, Susan E.. Emerging Infections Network, Carver College of Medicine, University of Iowa, 200 Hawkins Dr. SW-34JGH, Iowa City, IA 52242, USA
    • Polgreen, Philip M.. Emerging Infections Network, Carver College of Medicine, University of Iowa, 200 Hawkins Dr. SW-34JGH, Iowa City, IA 52242, USA
    • Marschall, Jonas. Division of Infectious Diseases, Washington University School of Medicine, 660 S. Euclid, St Louis, MO 63110, USA
    Dokumententyp
    • Postprint
    Sprache
    • Englisch
    Veröffentlicht in
    • Journal of Antimicrobial Chemotherapy, 2015, vol. 70, no. 12, p. 3397-3400. Oxford University Press
    Andere elektronische Ausgabe
    Klassifikation
    • Gesundheit
    OAI-PMH-ID
    • oai:doc.rero.ch:295401
    Summary
    Objectives The objective of this study was to attain a better understanding of infectious diseases (ID) physicians' experience with MDR organism (MDRO) urinary tract infections (UTIs) by means of a survey on disease perception, diagnostic management and treatment preferences. Methods A nine-question survey was developed and distributed to members of the North American Emerging Infections Network (EIN) in September 2013. Results Seven hundred and fourteen out of 1461 EIN members responded to the survey (49%). The responses of 603 responders were studied. Most providers perceived an increase in the incidence of MDRO UTIs over the past 3 years (75% of adult ID responders and 63% of paediatric ID responders). One hundred and thirty-four (22%) responders prefer intravenous over oral administration of antimicrobials when both are available, 171 (28%) prefer longer durations of therapy when comparing an MDRO with a susceptible isolate of the same species and 142 (24%) order a repeat urine culture as ‘proof of cure' after treating an MDRO UTI. Nevertheless, 530 (88%) responders perceived MDRO UTIs to be of similar severity as non-MDRO UTIs. Fifty-five percent of providers prescribed fosfomycin for MDRO UTI at least once; the most common prescribing pattern (among a wide spectrum of approaches) was a single dose (16%). Conclusions Future studies on MDRO UTIs should clarify the role of resistance in patient outcomes and the comparative efficacy of different antimicrobials. Of particular interest is fosfomycin, which is unrelated to other antibiotic classes and may take a more prominent role in treating MDRO cystitis